Disability and Rehabilitation · 2022 · 12 citations · 35 references
MedicinePharmacoeconomicsRehabilitation MedicineCost-effectiveness AnalysisCost-utility AnalysisProstheticsMyoelectric ProsthesesProsthetic CareProsthetic DevicesProsthetic RehabilitationUpper Extremity Function AssessmentUpper-limb ProstheticsComparative Cost-effectivenessCost-effectivenessEconomic Evaluation AppraisalEconomic Performance EvaluationIncremental Cost EstimationIncremental Cost-utility AnalysisProsthetic Outcome AssessmentProsthetic Outcome Measurement
PURPOSE: To investigate the costs, quality of life, and user experiences associated with upper limb prosthesis use, and to evaluate the cost-effectiveness of multi-grip compared to standard myoelectric hand prostheses (MHPs/SHPs). MATERIALS AND METHODS: The EQ-5D-5L to assess the quality of life, the patient-reported outcome measure to assess the preferred usage features of upper limb prosthesis (PUF-ULP), and a cost questionnaire (societal perspective) were completed by 242 prosthesis users (57% men; mean age = 58 years). Incremental cost-utility and cost-effectiveness ratios (ICUR/ICER) with respectively the EQ-5D-5L and PUF-ULP were calculated to compare MHPs with SHPs. Statistical uncertainty was estimated using bootstrapping. Netherlands Trial Registry number: NL7682. RESULTS: The mean yearly total costs related to prosthesis use of MHPs (€54 112) and SHPs (€23 501) were higher compared to prostheses with tools/accessories (€11 977), body-powered (€11 298), and cosmetic/passive prostheses (€10 132). EQ-5D-5L and PUF-ULP scores did not differ between prosthesis types. ICUR was €-728 833 per quality-adjusted life year; ICER was €-187 798 per PUF-ULP point gained. CONCLUSIONS: Myoelectric prostheses, especially MHPs, were most expensive compared to other prostheses, while no differences in quality of life and user experiences were apparent. MHPs were not cost-effective compared to SHPs. When prescribing MHPs, careful consideration of advantages over SHPs is recommended.
35
Paul A. Harris, Robert Taylor, Robert J. Thielke et al. · Journal of Biomedical Informatics · 2008 · 51.7K citations · Full text
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Michael Herdman, Claire Gudex, Andrew Lloyd et al. · Quality of Life Research · 2011 · 10K citations · Full text
Dutch Tariff for the Five-Level Version of EQ-5D
Matthijs Versteegh, Karin M. Vermeulen, Silvia Evers et al. · Value in Health · 2016 · 1.1K citations · Full text